AI assistant
Sending…
Emergent BioSolutions Inc. — Director's Dealing 2011
Mar 10, 2011
32870_dirs_2011-03-10_d057afe9-ce12-45fc-a195-050560fcc4cf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2011-03-08
Reporting Person: Keese Kyle (SVP, BioSciences Division)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-03-08 | Common Stock | F | 909 | $21.15 | Disposed | 8161 | Direct |
More from Emergent BioSolutions Inc.
Earnings Release
2026
Apr 30
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Mar 3